Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids - PubMed (original) (raw)

. 2019 Jan 2;26(1):222-235.e5.

doi: 10.1016/j.celrep.2018.12.028.

Mingfang Liao 1, Nan Zhou 2, Li Bao 1, Ke Ma 1, Zhongyong Zheng 1, Yujing Wang 3, Chang Liu 2, Wenzhao Wang 1, Jun Wang 4, Shuang-Jiang Liu 5, Hongwei Liu 6

Affiliations

Free article

Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids

Kai Wang et al. Cell Rep. 2019.

Free article

Abstract

We demonstrated the metabolic benefits of Parabacteroides distasonis (PD) on decreasing weight gain, hyperglycemia, and hepatic steatosis in ob/ob and high-fat diet (HFD)-fed mice. Treatment with live P. distasonis (LPD) dramatically altered the bile acid profile with elevated lithocholic acid (LCA) and ursodeoxycholic acid (UDCA) and increased the level of succinate in the gut. In vitro cultivation of PD demonstrated its capacity to transform bile acids and production of succinate. Succinate supplementation in the diet decreased hyperglycemia in ob/ob mice via the activation of intestinal gluconeogenesis (IGN). Gavage with a mixture of LCA and UDCA reduced hyperlipidemia by activating the FXR pathway and repairing gut barrier integrity. Co-treatment with succinate and LCA/UDCA mirrored the benefits of LPD. The binding target of succinate was identified as fructose-1,6-bisphosphatase, the rate-limiting enzyme in IGN. The succinate and secondary bile acids produced by P. distasonis played key roles in the modulation of host metabolism.

Keywords: FBPase; Parabacteroides distasonis; bile acids; metabolic disorders; succinate.

Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources